Free Trial

Corteva (CTVA) Stock Forecast & Price Target

Corteva logo
$56.42 -1.06 (-1.84%)
(As of 11:28 AM ET)

Corteva - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
4
Buy
14

Based on 19 Wall Street analysts who have issued ratings for Corteva in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 1 has given a sell rating, 4 have given a hold rating, and 14 have given a buy rating for CTVA.

Consensus Price Target

$65.41
15.94% Upside
According to the 19 analysts' twelve-month price targets for Corteva, the average price target is $65.41. The highest price target for CTVA is $73.00, while the lowest price target for CTVA is $53.00. The average price target represents a forecasted upside of 15.94% from the current price of $56.42.
Get the Latest News and Ratings for CTVA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Corteva and its competitors.

Sign Up

CTVA Analyst Ratings Over Time

TypeCurrent Forecast
12/24/23 to 12/23/24
1 Month Ago
11/24/23 to 11/23/24
3 Months Ago
9/25/23 to 9/24/24
1 Year Ago
12/24/22 to 12/24/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
14 Buy rating(s)
13 Buy rating(s)
16 Buy rating(s)
Hold
4 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
5 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$65.41$64.33$61.94$64.65
Forecasted Upside15.94% Upside5.07% Upside7.08% Upside36.22% Upside
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy

CTVA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CTVA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Corteva Stock vs. The Competition

TypeCortevaConsumer Staples CompaniesS&P 500
Consensus Rating Score
2.68
2.50
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside13.80% Upside46.16% Upside14.53% Upside
News Sentiment Rating
Positive News

See Recent CTVA News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
12/19/2024Royal Bank of Canada
4 of 5 stars
 Boost TargetOutperform ➝ Outperform$68.00 ➝ $73.00+29.25%
12/18/2024Citigroup
3 of 5 stars
P. Cunningham
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$70.00 ➝ $69.00+17.33%
11/21/2024KeyCorp
3 of 5 stars
 Boost TargetOverweight ➝ Overweight$66.00 ➝ $69.00+17.41%
11/20/2024Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$67.00 ➝ $69.00+18.97%
11/20/2024Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$65.00 ➝ $67.00+15.52%
11/8/2024Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetEqual Weight ➝ Equal Weight$58.00 ➝ $62.00+5.93%
11/8/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$69.00 ➝ $70.00+18.02%
11/7/2024UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$67.00 ➝ $71.00+23.07%
9/24/2024Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOverweight ➝ Overweight$65.00 ➝ $65.00+12.67%
8/7/2024Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
W. Selesky
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
8/2/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$57.00 ➝ $55.00+6.63%
6/18/2024Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$61.00 ➝ $60.00+15.27%
6/12/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$65.00 ➝ $65.00+25.90%
6/7/2024OTR Global
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingMixed ➝ Negative
5/3/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$60.00 ➝ $65.00+13.72%
5/3/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$64.00 ➝ $67.00+17.13%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$67.00+25.30%
2/12/2024Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$57.00 ➝ $65.00+21.27%
2/2/2024BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeUnderperform ➝ Neutral$53.00-1.96%
11/27/2023Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold$63.00 ➝ $52.00+11.42%
11/22/2023Roth Mkm
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$82.00 ➝ $63.00+36.45%
10/24/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetNeutral ➝ Neutral$65.00 ➝ $56.00+15.08%
8/4/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingOutperform ➝ Outperform$74.00+31.95%
7/25/2023Redburn Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Neutral
5/22/2023VNET Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingUpgrade
5/22/2023Vertical Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$67.00+17.61%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:48 AM ET.


Should I Buy Corteva Stock? CTVA Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, December 18, 2024. Please send any questions or comments about these Corteva pros and cons to contact@marketbeat.com.

Corteva
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Corteva, Inc.:

  • Corteva, Inc. has a strong consensus rating of "Moderate Buy" from analysts, indicating positive sentiment towards the stock's future performance.
  • The company recently announced a share repurchase program authorizing the buyback of up to $3.00 billion in shares, which suggests that management believes the stock is undervalued and can enhance shareholder value.
  • As of the latest trading session, Corteva, Inc. stock is priced at $62.26, which is near its 12-month high of $64.20, indicating strong market performance.
  • The company has a solid dividend yield of 1.09%, with a quarterly dividend of $0.17 per share, providing a steady income stream for investors.
  • Recent target price increases from major financial institutions, such as Bank of America raising it to $69.00, reflect growing confidence in Corteva's growth potential.

Corteva
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Corteva, Inc. for these reasons:

  • JPMorgan Chase & Co. recently lowered their target price for Corteva from $57.00 to $55.00, indicating a more cautious outlook on the stock.
  • One analyst has rated Corteva with a sell rating, which could signal potential risks or concerns about the company's future performance.
  • The stock has a relatively high price-to-earnings (P/E) ratio of 63.13, suggesting that it may be overvalued compared to its earnings, which could deter value-focused investors.
  • Corteva's quick ratio of 0.96 indicates that the company may have difficulty meeting its short-term liabilities, which could raise concerns about liquidity.
  • Despite the positive sentiment, the stock's beta of 0.77 suggests lower volatility compared to the market, which may not appeal to investors seeking high-growth opportunities.

CTVA Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for Corteva is $65.41, with a high forecast of $73.00 and a low forecast of $53.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Corteva in the last year. There is currently 1 sell rating, 4 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CTVA shares.

According to analysts, Corteva's stock has a predicted upside of 15.94% based on their 12-month stock forecasts.

Over the previous 90 days, Corteva's stock had 1 upgrade by analysts.

Corteva has been rated by research analysts at Bank of America, Barclays, Citigroup, KeyCorp, Morgan Stanley, Oppenheimer, Royal Bank of Canada, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Corteva more than other "consumer staples" companies. The consensus rating for Corteva is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CTVA compares to other companies.


This page (NYSE:CTVA) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners